Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-25

Clinical Trial Update: Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating lactoferrin added to standard triple therapy or sequential therapy for Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactoferrin (lactoferrin)

Snippet

Sponsor: Alexandria University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED